Other Trustworthy AI in clinical oversight BioPharma DiveAI can accelerate clinical work and preserve traceability, but only if users can trust it.OtherRead full story pharminent March 30, 2026 (Last updated: March 30, 2026) BioPharma Dive AI can accelerate clinical work and preserve traceability, but only if users can trust it. OtherRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Otsuka grows in neuroplastogens with $1.225bn Transcend buyNext: Amgen’s BiTE for lung cancer backed for EU approval Related Stories Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026 Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026
